Investor Relations

Investor Relations

HANTECH BIO-TECH CO., LTD. - Public Information Disclosure

A Message to Investors

HANTECH BIO-TECH was officially listed on the Taipei Exchange (TPEx) on September 26, 2024 (Stock Code: 1294). Guided by the business philosophy of "Combining Traditional Chinese Medicine with Western Medicine," HANTECH has been deeply engaged in the health supplement ODM sector for more than 30 years.

Leveraging its core retort pouch technology and a proven track record of more than 1200 commercialized formulations, HANTECH continues to create long-term value for shareholders and business partners. We sincerely invite investors to witness the company’s next stage of growth.

A Message to Investors
Public Information

Public Information

Information

Stock and Material Information

Contact Information

Investor Relations Contacts

Spokesperson

General Manager Wang Kuo-Hua
Phone
04-8811181
E-mail
spokesperson@htbios.com

Deputy Spokesperson

Chief Financial Officer Hsieh Chun-Yang
Phone
04-8811181
E-mail
IR@htbios.com

Stock Transfer Agency

Transfer Agency Department CTBC Bank Co., Ltd.
Phone
02-66365566
Address
5F., No. 83, Sec. 1, Chongqing S. Rd., Zhongzheng Dist., Taipei City 100, Taiwan (R.O.C.)